Stress granules are an integral part of the stress response that are formed from non-translating mRNAs aggregated with proteins. While much is known about stress granules, the factors that drive their mRNA localization are incompletely described. Modification of mRNA can alter the properties of the nucleobases and affect processes such as translation, splicing and localization of individual transcripts. The researchers show that the RNA modification N4-acetylcytidine (ac4C) on mRNA associates with transcripts enriched in stress granules and that stress granule localized transcripts with ac4C are specifically translationally regulated. They also show that ac4C on mRNA can mediate localization of proteins to stress granules. Their results suggest that acetylation of mRNA regulates localization of both stress-sensitive transcripts and RNA-binding proteins to stress granules and adds to our understanding of the molecular mechanisms responsible for stress granule formation.

Stress granules are membrane-less assemblies of mRNA-protein complexes that arise from mRNAs stuck in translation initiation. RNA-protein complexes are important for their formation and the mechanisms promoting stress granule formation involve both conventional RNA-protein interactions and interactions that encompass intrinsically disordered regions of proteins. Stress granules have been extensively studied, and it is well-established that they form when translation initiation is limited and a variety of roles for stress granules within the cell have been proposed. While stress granule assembly and disassembly can be regulated by various post-translational modifications the impact of RNA modifications on their formation, dispersal and function remains largely unclear.

The RNA modification N4-acetylcytidine (ac4C) has recently been shown to be deposited on mRNA and regulate translation efficiency. ac4C is conserved through all kingdoms of life and is induced upon several different stresses. ac4C is less abundant than other RNA modifications on mRNA and due to difficulties in precise and quantitative mapping its function and occurrence on mRNA has remained controversial.

The researchers show in their publication that ac4C is enriched in stress granules and that acetylated transcripts are predominantly localized to stress granules in response to oxidative stress, proposing a model where acetylation of RNA can affect mRNA localization to stress granules, in part by affecting the translational release of mRNA from the ribosome, providing new insight into both the function and consequences of mRNA acetylation and mechanism of RNA localization to stress granules.

The findings will promote the understanding of how the cells react to stress and which role RNA modifications play in the process. Both stress and RNA acetylation have implications in disease and their findings could help shed light on relevant molecular pathways that could be targeted in disease.

The project was led by Ulf A.V. Ørom’s lab at Aarhus University in Denmark, and the study involved collaboration with researchers from the University of Tartu, Norwegian Technical University, and the Max Planck Institute for Molecular Genetics in Berlin.

The findings have just been published in EMBO Reports.

SUPPLEMENTARY INFORMATION, INCLUDING CONTACT INFORMATION

We strive to ensure that all our articles live up to the Danish universities' principles for good research communication. Against this background, the article is supplemented with the following information:

Study type:

Experiment

External funding:

Lundbeck Foundation, Novo Nordisk Foundation, Carlsberg Foundation

Conflicts of interest:

None

Link to the scientific article:

N4-acetylcytidine (ac4C) promotes mRNA localization to stress granules

Pavel Kudrin, Ankita Singh, David Meierhofer, Anna Kuśnierczyk, Ulf Andersson Vang Ørom

Department of Molecular Biology and Genetics, Aarhus University, Denmark;
Institute of Biomedicine and Translational Medicine, University of Tartu, Estonia;
Department of Biomedicine, Aarhus University, Denmark;
Max Planck Institute for Molecular Genetics, Berlin, Germany;
Proteomics and Modomics Experimental Core (PROMEC), Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology and the Central Norway Regional Health Authority, Trondheim, Norway.

EMBO reports: https://www.embopress.org/doi/full/10.1038/s44319-024-00098-6

For more information, please contact:

Associate Professor Ulf Andersson Vang Ørom
Department of Molecular Biology and Genetics
Aarhus University, Denmark
E-mail: ulf.orom@mbg.au.dk – Mobile: +45 2228 8766